Discover

MBOT
Microbot Medical Inc.
1.80
1 x 1.77
1 x 1.80
bid
ask
+
0.01
0.56%
162 @ 04:00 PM
1.83 +0.03 (1.67%)
Ytd-10.00%
1y-26.53%
1.78
day range
1.83
1.60
52 week range
4.67
Open1.80Prev Close1.79Low1.78High1.83Mkt Cap82.03M
Vol510.49KAvg Vol1.27MEPS-0.26P/E-6.92Forward P/E-1.87
Beta1.04Short Ratio2.65Inst. Own7.46%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.87200-d Avg2.191yr Est7.00

MBOT News

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
globenewswire.com
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery

HINGHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

benzinga.com
Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu

benzinga.com
Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely

As momentum continues to rise in the U.S., reflected in increased accounts and usage across several

benzinga.com
Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu

benzinga.com
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) wi

benzinga.com
Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascul

benzinga.com
Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report O

https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-

benzinga.com
Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As

Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as

benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with

benzinga.com
Microbot Medical Completes Limited Market Release Of Its LIBERTY Endovascular Robotic System, With C

To date, LIBERTY has been adopted by multiple healthcare systems with dozens of hospitals in their n

benzinga.com
Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst

benzinga.com
Emory Healthcare Announces Successful Use Of Microbot Medical's Liberty System In Robotic Peripheral

Emory interventional radiologists have now demonstrated successful use of the LIBERTY System on beni

benzinga.com
Microbot Medical Commends American Medical Association's Expanding Efforts To Protect Health Care Pr

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascul

Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System
benzinga.com
Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System

Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead

benzinga.com
Microbot Medical Highlights LIBERTY Endovascular Robotic System At ISET Conference

International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advan

Looking Into Microbot Medical Inc's Recent Short Interest
benzinga.com
Looking Into Microbot Medical Inc's Recent Short Interest

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday
benzinga.com
This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tues

benzinga.com
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target o

B. Riley Securities analyst Anderson Schock initiates coverage on Microbot Medical (NASDAQ:MBOT)

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarke

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday morning, 446 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday